A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...

Abbott's Diabetes Care business continues to benefit from the growing sales of its flagship, sensor-based continuous glucose ...

Investors feel optimistic about Abbott's robust strength in the Core Diagnostics business. Yet, unfavorable forex impacts are concerning.

(Reuters) - Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects ...

In our view, Abbott's FreeStyle Libre blood glucose monitor franchise is one of the most compelling innovations the firm has ever launched. Further, the pandemic provided a boon to the diagnostics ...

to obtain blood samples. Two of the most commonly used alternative-site glucose monitors are the FreeStyle Flash (Abbott Diabetes Care, Alameda, CA) and the One Touch Ultra (LifeScan, Milpitas ...

The latest version of Abbott's FreeStyle Libre continuous glucose monitor is now available via ... Libre CGM range has been shown to improve blood glucose control, reducing hypoglycaemic and ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

and monitoring your condition regularly through glucometers or CGM devices (continuous glucose monitors), you can maintain healthy blood sugar ranges and reduce the risk of developing type 2 diabetes.

Abbott and Dexcom have agreed to settle all of their remaining international legal disputes over patents related to their continuous glucose monitors ... saying its FreeStyle Libre system ...